Covered recipient · General Payments record
JAMES D RUTTER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$487.06
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.45 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $76.29 | 7 |
| Exact Sciences Corporation | $42.47 | 2 |
| Novo Nordisk AS | $33.96 | 2 |
| DEXCOM, INC. | $22.71 | 1 |
| Amgen Inc. | $20.68 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.59 | 1 |
| GlaxoSmithKline, LLC. | $16.03 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.64 | 1 |
| Lundbeck LLC | $14.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.68 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111694168 | CMS |
| Corium, LLC | $13.47 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100116346 | CMS |
| Corium, LLC | $26.06 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100193886 | CMS |
| Corium, LLC | $5.81 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100146587 | CMS |
| Corium, LLC | $7.90 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100151087 | CMS |
| Corium, LLC | $5.37 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100145839 | CMS |
| Corium, LLC | $7.80 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100150885 | CMS |
| Corium, LLC | $9.88 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100154755 | CMS |
| Dexcom, Inc. | $22.71 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153306135 | CMS |
| Exact Sciences Corporation | $22.07 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114866146 | CMS |
| Exact Sciences Corporation | $20.40 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114866159 | CMS |
| GlaxoSmithKline, LLC. | $16.03 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116317672 | CMS |
| Lundbeck LLC | $14.08 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145963648 | CMS |
| Novartis Pharmaceuticals Corporation | $14.64 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087332567 | CMS |
| Novo Nordisk Inc | $16.07 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097796652 | CMS |
| Novo Nordisk Inc | $17.89 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097315982 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.59 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118973742 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.